ANXA5 and lung carcinoma: Additionally, they are in accordance with recent studies demonstrating that radiolabeled Annexin A5 allows for the in vivo monitoring of cell death in experimental lung cancer treated by cytotoxic therapy as well as in animal models of myocardial infarction [18,19].